Skip to content
★ Sign in to follow
HS

Hing Sham

Executive
Global Blood Therapeutics, Inc.
Total declarations
18
Company
1
▲ Purchases (1 ops.)
€37k
▼ Sales (0 ops.)
—

Latest filing published 09 Mar 2018 for Global Blood Therapeutics, Inc., €4,228.

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Hing Sham: trading record in brief

Hing Sham discloses dealings in Global Blood Therapeutics, Inc. to SEC (Form 4). Between 17 August 2015 and 7 March 2018, the trades on record add up to 18 filings.

Every open-market trade on record is a purchase: 1 purchase worth €37k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 6 share grants and 11 option exercises.

On 9 March 2018 came the latest disclosure, an option exercise for €4,228 in Global Blood Therapeutics, Inc. The latest purchase dates back some time: it was published 3,959 days ago, on 7 January 2016. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Hing Sham

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total

18 of 18 declarations